338 related articles for article (PubMed ID: 7958493)
1. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.
Féry F; Balasse EO
Diabetes; 1994 Dec; 43(12):1418-25. PubMed ID: 7958493
[TBL] [Abstract][Full Text] [Related]
2. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
[TBL] [Abstract][Full Text] [Related]
3. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
[TBL] [Abstract][Full Text] [Related]
4. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects.
Fulcher GR; Walker M; Catalano C; Agius L; Alberti KG
Diabetes; 1992 Nov; 41(11):1400-8. PubMed ID: 1397716
[TBL] [Abstract][Full Text] [Related]
6. Suppression of gluconeogenesis after a 3-day fast does not deplete liver glycogen in patients with NIDDM.
Clore JN; Blackard WG
Diabetes; 1994 Feb; 43(2):256-62. PubMed ID: 8288050
[TBL] [Abstract][Full Text] [Related]
7. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
[TBL] [Abstract][Full Text] [Related]
8. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
McMahon M; Marsh HM; Rizza RA
Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate tolerance improves with fasting in obese subjects with noninsulin-dependent (type II) diabetes.
Watts NB; DiGirolamo M
Am J Med Sci; 1990 Apr; 299(4):250-6. PubMed ID: 2181873
[TBL] [Abstract][Full Text] [Related]
10. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
[TBL] [Abstract][Full Text] [Related]
11. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA
Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856
[TBL] [Abstract][Full Text] [Related]
12. High plasma free fatty acids decrease splanchnic glucose uptake in patients with non-insulin-dependent diabetes mellitus.
Tomita T; Yamasaki Y; Kubota M; Tohdo R; Katsura M; Ikeda M; Nakahara I; Shiba Y; Matsuhisa M; Hori M
Endocr J; 1998 Apr; 45(2):165-73. PubMed ID: 9700469
[TBL] [Abstract][Full Text] [Related]
13. Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.
Scheen AJ; Paolisso G; Salvatore T; Lefèbvre PJ
Diabetes Care; 1991 Apr; 14(4):325-32. PubMed ID: 2060435
[TBL] [Abstract][Full Text] [Related]
14. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents.
Gulli G; Ferrannini E; Stern M; Haffner S; DeFronzo RA
Diabetes; 1992 Dec; 41(12):1575-86. PubMed ID: 1446799
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of starvation diabetes: a study with double tracer and indirect calorimetry.
Fery F; d'Attellis NP; Balasse EO
Am J Physiol; 1990 Dec; 259(6 Pt 1):E770-7. PubMed ID: 2260646
[TBL] [Abstract][Full Text] [Related]
16. Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast.
Clore JN; Post EP; Bailey DJ; Nestler JE; Blackard WG
J Clin Endocrinol Metab; 1992 Mar; 74(3):660-6. PubMed ID: 1740502
[TBL] [Abstract][Full Text] [Related]
17. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
[TBL] [Abstract][Full Text] [Related]
18. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
Kelley DE; Mokan M; Mandarino LJ
Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
[TBL] [Abstract][Full Text] [Related]
19. Intracellular defects in glucose metabolism in obese patients with NIDDM.
Kelley DE; Mokan M; Mandarino LJ
Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]